Stock 6497 ASLAN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar ASLAN Pharmaceuticals Limited Taipei Exchange

Equities

6497

KYG054241099

Chart calendar ASLAN Pharmaceuticals Limited

ade6.o4KkFZQazlbT_mjpKsP1KDaplc7M7zRXvuCDz3kD_9o.z-XXZMx0_zSYiz-tG7OZTGzD9K2UnXImjtSw4k1vuZP27egk7E-NHIatJQ~e027e0d6729fc6d196649afe5de11831

Upcoming events on ASLAN Pharmaceuticals Limited

2024-05-20 12:15 pm American Thoracic Society International Conference - Poster No 13753
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-10-24 Q3 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)

Past events on ASLAN Pharmaceuticals Limited

2024-04-24 Q1 2024 Earnings Release (Projected)
2024-04-12 08:00 am Q4 2023 Earnings Release
2024-03-28 08:00 am H.C. Wainwright Autoimmune and Inflammatory Disease Conference
2024-01-09 LifeSci Partners Corporate Access Event
2024-01-07 Biotech Showcase
2024-01-06 Dermatology Summit
2023-11-29 11:30 am Piper Sandler Healthcare Conference
2023-10-30 Dermatology Drug Development Summit
2023-10-27 08:00 am Q3 2023 Earnings Release
2023-10-24 11:00 am Investor Meeting - Key Opinion Leader
2023-09-11 10:30 am H.C. Wainwright Global Investment Conference
2023-08-11 07:00 am Q2 2023 Earnings Release
2023-07-06 08:30 am TREK-AD Phase 2b Trial Results Call
2023-06-08 04:30 pm Jefferies Global Healthcare Conference
2023-05-13 12:15 am International Societies for Investigative Dermatology Meeting - Abstract Number : LB1751
2023-05-09 International Societies for Investigative Dermatology Meeting - Abstract Number : LB1777
2023-05-09 International Societies for Investigative Dermatology Meeting - Abstract Number : 657
2023-05-09 International Societies for Investigative Dermatology Meeting - Abstract Number : 1594
2023-04-28 07:00 am Q1 2023 Earnings Release
2023-03-30 10:30 am H.C. Wainwright Autoimmune & Inflammatory Disease Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million TWD		Released
Forecast
Spread 		90,7
91,4
-0.81%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		387
379
2.21%
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million TWD		Released
Forecast
Spread 		-1 378
-674
-104.55%		-463
-402
-15.28%		-971
-889
-9.19%		-1 451
-1 404
-3.35%		-1 411
-1 321
-6.77%
-2 023

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-1 410
-682
-106.67%		-477
-427
-11.78%		-906
-850
-6.61%		-1 554
-1 506
-3.23%		-1 422
-1 347
-5.55%
-2 135

Net income
Million TWD		Released
Forecast
Spread 		-1 421
-694
-104.65%		-455
-423
-7.7%		-898
-857
-4.76%		-1 557
-1 506
-3.39%		-1 427
-1 350
-5.64%
-2 135

EPS
USD		Released
Forecast
Spread 		-7,25
-3,70
-95.95%		-2,00
-1,43
-39.54%		-2,40
-2,38
-0.7%		-3,68
-2,12
-74%		-2,69
-2,61
-3.07%
-3,62

Announcement Date18/03/2022/04/2125/03/2224/03/2312/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million TWD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		381
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million TWD		Released
Forecast
Spread 		-319
-258
-23.66%		-349
-291
-19.94%		-369
-372
0.85%		-330
-394
16.46%		-406
-349
-16.18%		-557
-398
-39.89%		-75,2
-479
84.29%		-338
-460
26.43%		-414
-346
-19.63%
-372


-385


-385


-881


-380

Earnings before Tax (EBT)
Million TWD		Released
Forecast
Spread 		-262
-268
2.24%		-380
-310
-22.47%		-391
-403
3.07%		-349
-425
17.76%		-436
-378
-15.33%		-588
-423
-39.15%		-58,1
-527
88.97%		-314
-494
36.35%		-435
-381
-14.03%
-399


-412


-413


-911


-420

Net income
Million TWD		Released
Forecast
Spread 		-262
-277
5.41%		-380
-310
-22.47%		-391
-419
6.77%		-350
-425
17.69%		-439
-378
-15.97%		-588
-423
-39.2%		-59,9
-496
87.91%		-315
-494
36.16%		-436
-381
-14.37%
-399


-412


-413


-911


-420

EPS
USD		Released
Forecast
Spread 		-0,80
-0,72
-11.63%		-0,95
-0,90
-5.56%		-0,95
-0,60
-58.33%		-0,80
-0,95
15.79%		-1,04
-0,55
-90.83%		-1,29
-0,44
-196.55%		-0,11
-0,80
86.25%		-0,56
-0,77
27.27%		-0,79
-0,65
-21.54%
-0,61


-0,54


-0,53


-1,87


-0,56

Announcement Date25/03/2227/04/2212/08/2228/10/2224/03/2328/04/2311/08/2327/10/2312/04/24-----

Upcoming sector events for ASLAN Pharmaceuticals Limited

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for ASLAN Pharmaceuticals Limited

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. ASLN Stock
  4. 6497 Stock
  5. Calendar ASLAN Pharmaceuticals Limited